Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Consuela Cheriece Yousef
Observed names:
Consuela C Yousef,
Consuela C. Yousef,
Consuela Yousef,
Yousef, Consuela,
Yousef, Consuela Cheriece
Institutions:
King Saud bin Abdulaziz University for Health Sciences,
King Abdullah International Medical Research Center,
Imam Abdulrahman Al Faisal Hospital,
National Guard Health Affairs
Observed institutions:
King Saud bin Abdulaziz University for Health Sciences,
King Abdullah International Medical Research Center,
Imam Abdulrahman Al Faisal Hospital,
National Guard Health Affairs
ORCID:
0000-0001-6386-7582
Observed ORCID:
0000-0001-6386-7582
OpenAlex ID:
A5080538088
Health Care Providers’ Acceptance of a Personal Health Record: Cross-sectional Study
2021
·
Consuela Cheriece Yousef
, Teresa M Salgado
, et al.
·
Journal of Medical Internet Research
·
37
PDF
Adoption of a Personal Health Record in the Digital Age: Cross-Sectional Study
2020
·
Consuela Cheriece Yousef
, Abin Thomas
, et al.
·
Journal of Medical Internet Research
·
36
PDF
The effect of job and personal demands and resources on healthcare workers’ wellbeing: A cross-sectional study
2024
·
Consuela Cheriece Yousef
, Ali Farooq
, et al.
·
PLoS ONE
·
34
PDF
Predicting Patients’ Intention to Use a Personal Health Record Using an Adapted Unified Theory of Acceptance and Use of Technology Model: Secondary Data Analysis
2021
·
Consuela Cheriece Yousef
, Teresa M Salgado
, et al.
·
JMIR Medical Informatics
·
29
PDF
Liraglutide effects on glycemic control and weight in patients with type 2 diabetes Mellitus: A real-world, observational study and brief narrative review
2021
·
Consuela Cheriece Yousef
, Abin Thomas
, et al.
·
Diabetes Research and Clinical Practice
·
27
PDF
Fixed dose combinations: A formulary decision guide
2021
·
Laila Carolina Abu Esba
, Consuela Yousef
, et al.
·
Health Policy and Technology
·
18
PDF
An Institutional Guide for Formulary Decisions of Biosimilars
2022
·
Sherin Ismail
, Laila Abu Esba
, et al.
·
Hospital Pharmacy
·
14
Changing paradigms in detecting rare adverse drug reactions: from disproportionality analysis, old and new, to machine learning
2022
·
Daniel Arku
, Consuela Yousef
, et al.
·
Expert Opinion on Drug Safety
·
14
PDF
The landscape of biosimilars in Saudi Arabia: preparing for the next decade
2023
·
Abdulaali R. Almutairi
, Ali M. Al-Samil
, et al.
·
Expert Opinion on Biological Therapy
·
12
Perceived barriers and enablers of a personal health record from the healthcare provider perspective
2023
·
Consuela C Yousef
, Teresa M Salgado
, et al.
·
Health Informatics Journal
·
12
PDF
Predicting Health Care Providers' Acceptance of a Personal Health Record Secure Messaging Feature
2022
·
Consuela C. Yousef
, Teresa M. Salgado
, et al.
·
Applied Clinical Informatics
·
12
PDF
P&T Committee Drug Prioritization Criteria: A Tool Developed by a Saudi Health Care System.
2018
·
Laila Carolina Abu Esba
, Hind Almodaimegh
, et al.
·
Europe PMC (PubMed Central)
·
10
Cost-efficiency analysis of conversion to biosimilar filgrastim for supportive cancer care and resultant expanded access analysis to supportive care and early-stage HER2+ breast cancer treatment in Saudi Arabia: simulation study
2023
·
Consuela Cheriece Yousef
, Mansoor Ahmed Khan
, et al.
·
Journal of Medical Economics
·
8
PDF
Off-Label Drug Use in Pediatric Out-Patient Care: A Multi-Center Observational Study
2020
·
Aeshah AlAzmi
, Zahra Alasmari
, et al.
·
Hospital Pharmacy
·
7
A strategic framework for synergizing managed entry agreement efforts to access pharmaceutical products in Saudi Arabia—results from a multi-stakeholder workshop
2025
·
Hussain Abdulrahman Al-Omar
, Asma Abdulaziz Almuhsin
, et al.
·
Journal of Medical Economics
·
4
Practical challenges and considerations in adopting biosimilars in oncology clinical practice within a large healthcare system
2025
·
Mansoor A. Khan
, Laila Carolina Abu Esba
, et al.
·
Expert Review of Clinical Pharmacology
·
4
A Formulary Management Group Consensus
2024
·
Laila Carolina Abu Esba
, Hind Almodaimegh
, et al.
·
Global Journal on Quality and Safety in Healthcare
·
4
PDF
Mapping the landscape of managed entry agreements: a systematic review of global frameworks, system-level components, and implementation challenges
2026
·
Hussain Abdulrahman Al-Omar
, Asma Abdulaziz Almuhsin
, et al.
·
Frontiers in Pharmacology
·
2
PDF
Challenges in evaluation and reimbursement of drugs for rare diseases in Saudi Arabia: a Delphi expert consensus
2025
·
Laila Carolina Abu Esba
, Consuela Cheriece Yousef
, et al.
·
Journal of Pharmaceutical Policy and Practice
·
1
PDF
HPR10 A Strategic National Framework for Managed Entry Agreements to Access Innovative and Breakthrough Medications in Saudi Arabia
2025
·
Hussain Abdulrahman Al-Omar
, Asma Abdulaziz Al-Muhsin
, et al.
·
Value in Health
Show more works
View as search
Works count:
22
Citation count:
291
H-index:
11
I10-index:
12
Year
Topic
Type